Advertisement

Topics

Health Economics and Clinical Decision Making in Psoriasis

08:00 EDT 14 Jun 2018 | Medscape

While biological treatments for plaque psoriasis are highly effective and safe, they are also expensive. How can we prioritize their use while balancing cost-effectiveness?
The British Journal of Dermatology

Original Article: Health Economics and Clinical Decision Making in Psoriasis

NEXT ARTICLE

More From BioPortfolio on "Health Economics and Clinical Decision Making in Psoriasis"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Psoriasis
Psoriasis is a common skin condition affecting 2-3% of the population of the United Kingdom, where the skins replacement process is sped taking 2-6 days instead of the usual 21 - 28 days for the replacement of skin cells. Patients experience an accumulat...